IonicsMSV, a sister company of MS Vision has announced the launch of a new triple quadrupole mass spectrometer and data acquisition and processing system: the IONICS 3Q Molecular Analyzer™ and MolAna™, respectively. The IONICS 3Q Molecular Analyzer™ triple quadrupole mass spectrometer is a new generation instrument that incorporates many novel technology advancements.
“The Ionics 3Q Molecular Analyzer has many unique features leading to the highest sensitivity, ease of use and ruggedness”, said Dr. Reza Javahery, President. We are extremely proud of our new design, with its high sensitivity, small footprint, sophisticated diagnostics, easy serviceability, and low maintenance.” The IONICS 3Q Molecular Analyzer™ triple quadrupole mass spectrometer is equipped with a single or dual atmospheric pressure electrospray or chemical ionization source, multiple pressure stages, a collision cell, two resolving rods, and a pulse counting detector capable of high dynamic range. A vertical ion path provides uniquely small instrument foot print. “The ion transport from the source through the interface and all the way through to the first quadrupole is “flow based” along the ion path with gradually decreasing pressure. This technology significantly improves ion transmission and ease of use.” said Dr. Lisa Cousins, Vice President Research. “We worked extensively for a long time with our collaborators from the industry and academia, and we are convinced we were able to provide the instrument they were asking for.
” MolAna™, developed for Ionics by Phenomenome Discoveries Inc. (PDI) of Saskatoon Canada, is a complete data acquisition and quantitation software package that is designed to work in today’s multi-instrument, multi-vendor laboratory environments. In addition to an innovative workflow inspired instrument control interface, MolAna™ introduces new universal quantitation package that enables the user to extract and perform quantitation from data collected in virtually any analysis mode from virtually any instrument vendor. These functionalities are fully integrated with PDI’spatented non-targeted biomarker discovery technology, Phenomenome Profiler™.
